Read news as it happens
Create a Rediffmail account
Subscribe via RSS
Wockhardt launches prostate drug in US market
Pharma major Wockhardt on Wednesday said it has launched Tamsulosin capsules, indicated for problem of prostate enlargement, in the US market on the day one of the expiry of patent covering the......
Ranbaxy faces more trouble in US
In addition to the US drug regulator, Food and Drug Administration, and rival pharma majors that appear keen to launch litigation against Indian company Ranbaxy, a US citizen has joined the......
Peace on patents to boost Ranbaxy
Ranbaxy Laboratories, India's largest pharmaceutical drug firm by sales, expects its recent patent litigation settlements to add significantly to its revenues as well as net profit. The numbers......
Meet Malav, the charismatic CEO of Ranbaxy
In the two years since becoming CEO, Malvinder Mohan Singh has systematically purged risk out of Ranbaxy's model. Malvinder Mohan Singh, 35, does not mind wearing a T-shirt in office - tucked in.......
Reversals for Ranbaxy
India's largest drug maker Ranbaxy was at the receiving end of two patent infringement cases in Denmark and the USA on February 23. In the first case, a Danish court temporarily crushed the......
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2017 Rediff.com
India Abroad weekly